Category Archives: The Charlton Centre

Charlton Health is pleased to launch a video explaining biosimilars.  We have received many questions about switching from an originator biologic to a biosimilar and this video will help support these questions. We would love your feedback on this video … Continue reading →

We are very excited to announce that the Canadian Spondylitis Association has added a great tool for patients to their website. This tool was developed by our own clinical pharmacist, Carolyn Whiskin.  The tool was designed to assist patients with rheumatic autoimmune … Continue reading →

Many of the advanced therapies for autoimmune diseases are protein-based medications we refer to as biologics. To avoid stomach digestion, which would render at this medication ineffective, they are given by subcutaneous injection (just under the skin) or infusion. Many … Continue reading →

March is the month we celebrate the pharmacy profession, and the role pharmacists play in patient care.  As pharmacists at Charlton Health, working with our patients and health professional colleagues across Ontario is a privilege.  We appreciate the trust you … Continue reading →

At Charlton Health we specialize in providing biologic medications for many autoimmune conditions.  Some of these medications have been on the Canadian market for several years and their patent to be the only company who can make the medicine has … Continue reading →

Many of our patients have indicated they are planning a vacation over the winter months to a sunny destination. It is important to note that medication requiring refrigeration is to be kept at 2-8oC during your journey. To ensure the … Continue reading →

Publicly funded shingles vaccination has been available for many years for adults aged 65-70. Initially, the vaccine provided was Zostavax, which was a live vaccine given as a single dose. Protection decreased with time and by 8 years, very little … Continue reading →

Happy New Year to our Charlton Family! We enter 2023 with much excitement as treatments for autoimmune diseases continue to expand making our ‘tool chest” bigger. Therapies marketed for psoriasis and psoriatic arthritis are being approved for inflammatory bowel diseases, … Continue reading →

As we near the end of 2022, we thought we would share some of our most popular blog posts of the past year with you. We’ve talked about a huge number of subjects this year, but these ones were your … Continue reading →